13F Pro Quality Score

30.3/100

Rank #2,493 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

CITR Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for CitroTech Inc. (CITR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CITR at 30.3/100 on a 32-signal composite quality model, placing it at rank #2,493 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), CitroTech Inc. reports quarterly revenue of $280.7K, net income of $-3.9M, free cash flow of $-1.8M. Top institutional holders of CITR by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, FIFTH THIRD BANCORP, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. CITR trades on the NYSE exchange and files with the SEC under CIK 894556. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CITR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CitroTech Inc. directly from SEC EDGAR. CitroTech Inc.'s 13F Pro composite quality score has ranged between 24 and 30 since 2026, currently 30.3 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q2 2026

$280.7K

Net Income

Q2 2026

$-3.9M

Free Cash Flow

Q2 2026

$-1.8M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+194.6% YoY
$2.4MFY 2025
FY22 $62.7KFY23 $520.6KFY24 $808.4KFY25 $2.4M

Net Income

-435.3% YoY
$-36.8MFY 2025
FY22 $-2.9MFY23 $-10.1MFY24 $-6.9MFY25 $-36.8M

Operating Income

-211.0% YoY
$-16.5MFY 2025
FY22 $-2.9MFY23 $-10.1MFY24 $-5.3MFY25 $-16.5M

EPS (Diluted)

-261.0% YoY
$-2.96FY 2025
FY22 $0.00FY23 $0.00FY24 $-0.82FY25 $-2.96

Total Assets

+158.9% YoY
$14.2MFY 2025
FY22 $4.4MFY23 $5.3MFY24 $5.5MFY25 $14.2M

Total Debt

FY 2025
FY22 FY23 $0.00FY24 $193.7KFY25

Op. Cash Flow

-202.9% YoY
$-5.9MFY 2025
FY22 $-708.5KFY23 $-1.2MFY24 $-1.9MFY25 $-5.9M

Free Cash Flow

-212.9% YoY
$-6.1MFY 2025
FY22 $-713.8KFY23 $-1.2MFY24 $-1.9MFY25 $-6.1M

Get alerted when CITR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CitroTech Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of CITR

Put CITR on your watchlist

Track score changes the day CitroTech Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CITR a good stock to buy?

13F Pro's AI-powered analysis of CitroTech Inc. (CITR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CITR are available on the CITR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CITR is classified as a small company.

Which hedge funds own CITR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CITR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CitroTech Inc.'s investment landscape.